Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apex Molecular is a UK-based chemistry contract research organization that provides specialist synthetic and medicinal chemistry services to pharmaceutical, biotechnology, and applied chemical customers. The company focuses on laboratory-scale custom synthesis, contract synthesis, medicinal chemistry support, and high-potency chemistry, including payload and warhead synthesis for antibody-drug conjugate programs. Its services support drug discovery from hit identification and lead optimization through preclinical toxicology batch preparation and transfer toward GMP manufacturing via external partners. Apex Molecular appears to operate primarily as a fee-for-service chemistry partner rather than a therapeutics developer with an internal clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apex Molecular Laboratories.